Form D · Biotechnology
Deka Biosciences, Inc.
Germantown, MD · CIK 0001893069
Offering snapshot reported Dec 8, 2023 · SEC filing
- Reported sold
- $29.9M Offering amount: $41.4M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 6, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2023 | Initial | $29,851,474 | No comparison | 33 | SEC filing |
| Nov 23, 2021 | Initial | $15,886,660 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-499203
Source: Form D, filed Dec 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Detlev Biniszkiewicz | Director |
| Peter Buzy | Director |
| Rakhshita Dhar | Director |
| Lu Han | Director |
| Lucio Iannone | Director |
| Christian Kanady | Director |
| Pavel Khrimian | Executive |
| John Mumm | Director, Executive |
| Vera Mumm | Executive |
| Sally (Yuanheng) Wang | Director |
| Christopher Yaen | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20378 Seneca Meadows Pkwy
Germantown, MD, 20876
Germantown, MD, 20876